Showing items 1 - 2 of 2

Your selections:

COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children’s Haematology/Oncology Group consensus statement

- Furlong, Eliska, Kotecha, Rishi S., Phillips, Marianne B., Padhye, Bhavna, Dalla-Pozza, Luciano, Alvaro, Frank, Fraser, Christopher J., Nicholls, Wayne, Clark, Julia E., O'Connor, Matthew, Saxon, Benjamin R., Tapp, Heather, Conyers, Rachel, Heath, John, Hunter, SE, Tsui, K, Winstanley, M, Lyver, A, Best, EJ, Wadia, U, Yeoh, D, Blyth, CC, Gottardo, NG, O'Brien, Tracey A., Hansford, Jordan R., Super, Leanne, Downie, Peter, Eisenstat, David D., Haeusler, Gabrielle, McMullan, Brendan

Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia

- Mateos, Marion K., Marshall, Glenn M., Alvaro, Frank, Mechinaud, Françoise, Catchpoole, Daniel, Lawson, John A., Chenevix-Trench, Georgia, MacGregor, Stuart, Kotecha, Rishi S., Dalla-Pozza, Luciano, Trahair, Toby N., Barbaro, Pasquale M., Quinn, Michael C. J., George, Carly, Mayoh, Chelsea, Sutton, Rosemary, Revesz, Tamas, Giles, Jodie E., Barbaric, Draga

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit